Tech Company Financing Transactions
ReAlta Life Sciences Funding Round
ReAlta Life Sciences secured a $14 million Series A funding round on 4/22/2020. Investors included Children's Research Holdings, Marathon Pharmaceuticals and private investors.
Transaction Overview
Company Name
Announced On
4/22/2020
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Proceeds Purpose
The additional capital raised will support the advancement of our lead program of HIE toward the clinic, as well as its utilization in other inflammatory disorders.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5665 Lowery Rd. 100
Norfolk, VA 23502
USA
Norfolk, VA 23502
USA
Phone
Website
Email Address
Overview
ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of the immune system through its PIC1 technology platform, comprised of a family of over 160 engineered peptides, to address life-threatening medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ulrich Thienel
Chief Financial Officer
John Rickman
Chief Medical Officer
Kenji Cunnion
Chief Scientific Officer
Neel Krishna
Vice President
Linda Dell
Browse more venture capital transactions:
Prev: 4/22/2020: Profitero venture capital transaction
Next: 4/22/2020: Biobot Analytics venture capital transaction
Share this article
About Our VC Transactions Data
We document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs